Benzinga's Top Upgrades, Downgrades For March 9, 2018

Top Upgrades

• Susquehanna upgraded Helmerich & Payne, Inc. HP from Neutral to Positive. Helmerich & Payne shares fell 0.15 percent to close at $65.02 on Thursday.
• JP Morgan upgraded Commercial Metals Company CMC from Neutral to Overweight. Commercial Metals shares fell 3.56 percent to close at $25.20 on Thursday.
• Gabelli & Co. upgraded Navistar International Corp NAV from Hold to Buy. Navistar shares rose 3.05 percent to close at $38.17 on Thursday.
• Analysts at JMP Securities upgraded Kennedy-Wilson Holdings Inc KW from Market Perform to Market Outperform. Kennedy-Wilson rose 0.89 percent to close at $17.00 on Thursday.
• BTIG Research upgraded Nutanix Inc NTNX from Neutral to Buy. Nutanix shares rose 2.76 percent to $47.60 in pre-market trading.
• Cowen & Co. upgraded Kohl's Corporation KSS from Market Perform to Outperform. Kohl's shares rose 0.98 percent to $62.80 in pre-market trading.
• JP Morgan upgraded Akamai Technologies, Inc. AKAM from Neutral to Overweight. Akamai shares rose 1.89 percent to $76.50 in pre-market trading.
• Analysts at Mizuho upgraded Concert Pharmaceuticals Inc CNCE from Neutral to Buy. Concert Pharmaceuticals shares rose 0.14 percent to close at $22.12 on Thursday.

Top Downgrades

• Analysts at Wells Fargo downgraded Match Group Inc MTCH from Outperform to Market Perform. Match Group shares fell 1.94 percent to $43.50 in pre-market trading.
• JP Morgan downgraded Fortive Corp FTV from Overweight to Neutral. Fortive shares fell 0.63 percent to $77.87 in pre-market trading.
• B. Riley downgraded Autoweb Inc AUTO from Buy to Neutral. AutoWeb shares fell 34.37 percent to $4.45 in pre-market trading.
• Needham downgraded Finisar Corporation FNSR from Buy to Hold. Finisar shares fell 10.48 percent to $18.10 in pre-market trading.
• Credit Suisse downgraded Ranger Energy Services Inc RNGR from Outperform to Neutral. Ranger Energy shares fell 1.36 percent to close at $8.71 on Thursday.
• Piper Jaffray downgraded Insys Therapeutics Inc INSY from Neutral to Underweight. Insys Therapeutics shares declined 10.69 percent to $6.85 in pre-market trading.
• SunTrust Robinson Humphrey downgraded SL Green Realty Corp SLG from Buy to Hold. SL Green Realty shares fell 0.61 percent to close at $99.47 on Thursday.
• Morgan Stanley downgraded Acacia Communications, Inc. ACIA from Equal-Weight to Underweight. Acacia Communications shares dropped 3.97 percent to $40.37 in pre-market trading.
• Chardan Capital downgraded Vascular Biogenics Ltd VBLT from Buy to Neutral. Vascular Biogenics shares fell 1.89 percent to $2.60 in pre-market trading.
• Keefe Bruyette & Woods downgraded XL Group Ltd. XL from Outperform to Market Perform. XL Group shares rose 0.09 percent to close at $55.80 on Thursday.

Top Initiations

• RBC Capital initiated coverage on Proteostasis Therapeutics Inc PTI with an Outperform rating. The price target for Proteostasis Therapeutics is set to $11. Proteostasis Therapeutics shares closed at $3.61 on Thursday.
• Wells Fargo initiated coverage on Endocyte, Inc. ECYT with an Outperform rating. The price target for Endocyte is set to $20. Endocyte shares closed at $8.06 on Thursday.
• Evercore ISI Group initiated coverage on Miragen Therapeutics, Inc. MGEN with an Outperform rating. The price target for Miragen Therapeutics is set to $19. Miragen Therapeutics shares closed at $6.44 on Thursday.
• Bernstein initiated coverage on Kroger Co KR with a Market Perform rating. The price target for Kroger is set to $27. Kroger shares closed at $22.98 on Thursday.
• Cowen & Co initiated coverage on Rocket Pharmaceuticals Inc RCKT with an Outperform rating. Rocket Pharmaceuticals shares closed at $17.97 on Thursday.
• Analysts at DA Davidson initiated coverage on Hortonworks Inc HDP with a Buy rating. The price target for Hortonworks is set to $24. Hortonworks shares closed at $20.44 on Thursday.
• Analysts at Piper Jaffray initiated coverage on Ovid Therapeutics Inc OVID with an Overweight rating. The price target for Ovid Therapeutics is set to $20. Ovid Therapeutics closed at $8.00 on Thursday.
• Analysts at Morgan Stanley initiated coverage on Finisar Corporation FNSR with an Equal-Weight rating. The price target for Finisar is set to $21. Finisar shares closed at $20.22 on Thursday.
• Stifel Nicolaus initiated coverage on Nutanix Inc NTNX with a Buy rating. The price target for Nutanix is set to $52. Nutanix shares closed at $46.32 on Thursday.
• Analysts at Loop Capital initiated coverage on Urban Outfitters, Inc. URBN with a Buy rating. The price target for Urban Outfitters is set to $46. Urban Outfitters closed at $35.13 on Thursday.